Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer.
Journal: Frontiers in oncology
Published: September 27, 2023
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
Journal: American journal of clinical oncology
Published: June 14, 2022
Transformational Changes Between Non-Small Cell and Small Cell Lung Cancer-Biological and Clinical Relevance-A Review.
Journal: American journal of clinical oncology
Published: September 05, 2020
The clinical significance of soluble PD-1 and PD-L1 in lung cancer.
Journal: Critical reviews in oncology/hematology
Published: June 19, 2019
Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC).
Journal: Cancer medicine
Published: December 05, 2018
Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis.
Journal: Journal of thoracic disease
Published: December 04, 2018
Beta blockade as adjunctive breast cancer therapy: A review.
Journal: Critical reviews in oncology/hematology
Published: October 25, 2018
Screening Patients with Esophageal Cancer to Determine Eligibility for Adjuvant Treatment Trials.
Journal: Anticancer research
Published: May 06, 2018
Financial impact of oral chemotherapy wastage on society and the patient.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 27, 2018
Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 24, 2018
Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
Journal: The Annals of otology, rhinology, and laryngology
Published: January 10, 2018
Last Updated: 09/26/2026